Clinical Trials Directory

Trials / Completed

CompletedNCT05362006

Exopulse Mollii Suit, Spasticity & Tissue Oxygenation

The Effects of a TENS System (Transcutaneous Electric Nerve Stimulation) on Spasticity and Muscular Oxygenation in Patients With Multiple Sclerosis (ENNOX Study)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
28 (actual)
Sponsor
Institut De La Colonne Vertebrale Et Des Neurosciences · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Spasticity is a frequent and debilitating symptom in patients with multiple sclerosis (MS). Sustained contractile activity, such as that observed in spastic muscles, could reduce the capillary density and induce important changes in the muscular microcirculation, leading to oxidative changes within the muscular tissue. Such changes reflect altered aerobic metabolism and impaired mitochondrial function. The available therapeutic strategies for treating spasticity and related symptoms are usually faced with limited efficacy and numerous side effects. For these reasons, non-invasive stimulation techniques, namely transcutaneous stimulation by means of Exopulse Mollii suit, might be of help in this context.

Conditions

Interventions

TypeNameDescription
DEVICEExopulse Mollii SuitExopulse Mollii suit is a new assistive device that has been developed by Exoneural Network (initially Inerventions AB), a Swedish med-tech company. Exopulse Mollii suit is a full-body garment with integrated 58 electrodes that can transcutaneously stimulate 40 groups of muscles. This stimulation is not intended to obtain a motor effect (contraction of the muscles in question), but rather to decrease the spasticity in spastic muscles by activating the antagonistic muscles via the physiological mechanism of reciprocal inhibition. The device is CE labelled and is intended to use for reducing spasticity and improving blood circulation. The outfit is very easy to put on, it can be used for one hour every day and the analgesic effects last 24 hours or more.
DEVICEExopulse Mollii suit (sham)In the sham condition, the control unit will be programmed to start stimulating for 1 minute then it will shut off.

Timeline

Start date
2022-03-01
Primary completion
2023-04-18
Completion
2023-05-30
First posted
2022-05-05
Last updated
2025-06-26

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05362006. Inclusion in this directory is not an endorsement.